-
-
-
-
-
-
-
Allogene Therapeutics, Inc. (ALLO) Tops Q1 EPS by 1c
-
-
-
-
-
-
-
Allogene (ALLO) PT Raised to $3.85 at Bernstein SocGen Group
-
-
-
-
-
-
-
Jefferies Assumes Allogene (ALLO) at Buy
-
-
-
-
-
-
-
Allogene Therapeutics, Inc. (ALLO) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
Allogene (ALLO) PT Lowered to $7 at Oppenheimer
-
-
-
-
-
-
-
Allogene Therapeutics (ALLO) Granted Three FDA Fast Track Designations for ALLO-329,
-
-
-
-
-
-
-
Allogene Therapeutics (ALLO) Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases
-
468,713 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

